Lv1
40 积分 2024-05-14 加入
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors and PROTAC-based degraders for cancer therapy
3小时前
已完结
Metabolic communication in the tumour–immune microenvironment
1天前
已完结
Journey of PROTAC: From Bench to Clinical Trial and Beyond
2个月前
已完结
Serotonin a la carte: Supplementation with the serotonin precursor 5-hydroxytryptophan
4个月前
已完结
Characterization of the human homolog of the IL-4 induced gene-1 (Fig1)
7个月前
已完结
Mitochondrial Protease Targeting Chimeras for Mitochondrial Matrix Protein Degradation
7个月前
已完结
Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer
10个月前
已完结
Discovery of Potent PROTACs Targeting EGFR Mutants through the Optimization of Covalent EGFR Ligands
10个月前
已完结
Rational Design for Nitroreductase (NTR)-Responsive Proteolysis Targeting Chimeras (PROTACs) Selectively Targeting Tumor Tissues
10个月前
已完结
Discovery of potent epidermal growth factor receptor (EGFR) degraders by proteolysis targeting chimera (PROTAC)
10个月前
已完结
皖公网安备34019202002308
